GE Vernova Inc. (GEV) concluded trading on Thursday at a closing price of $251.22, with 2.81 million shares of worth about $707.01 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 91.41% during that period and on September 26, 2024 the price saw a loss of about -1.50%. Currently the company’s common shares owned by public are about 274.80M shares, out of which, 274.44M shares are available for trading.
Stock saw a price change of 2.77% in past 5 days and over the past one month there was a price change of 35.39%. Over the period of past 52 weeks, stock dropped to lowest price of $115.00 but also hit the highest price of $257.75 during that period. The average intraday trading volume for GE Vernova Inc. shares is 2.93 million. The stock is currently trading 14.87% above its 20-day simple moving average (SMA20), while that difference is up 30.81% for SMA50 and it goes to 45.30% higher than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
GE Vernova Inc. (NYSE: GEV) currently have 274.80M outstanding shares and institutions hold larger chunk of about 80.51% of that.
The stock has a current market capitalization of $69.04B. It has Quick Ratio of 0.74 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for GEV, volatility over the week remained 3.17% while standing at 3.96% over the month.
Stock’s fiscal year EPS is expected to rise by 247.92% while it is estimated to increase by 105.72% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Truist on Sep-27-24 offering a Buy rating for the stock and assigned a target price of $300 to it. On September 24, 2024, Guggenheim Initiated their recommendations, while on September 17, 2024, BofA Securities Upgrade their ratings for the stock with a price target of $300. Stock get an Overweight rating from Barclays on September 16, 2024.
